Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children
Clinical trial NCT01988857 · COMPLETED
Trial details
- NCT number
- NCT01988857
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-22
- Primary completion
- 2014-05-10
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.